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Carotid endarterectomy for treatment of in-stent
restenosis after carotid angioplasty and stenting
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Johanna M. Hendriks, MD,b Hence J. M. Verhagen, MD, PhD,b Frans L. Moll, MD, PhD,a and
Gert Jan de Borst, MD, PhD,a Utrecht, Rotterdam, and Nieuwegein, The Netherlands
Objective: Carotid angioplasty and stenting (CAS) has emerged as an alternative for carotid endarterectomy (CEA) in the
prevention of stroke. The benefit of the procedure, however, is hampered by a suggested higher incidence of in-stent
restenosis (ISR) for CAS relative to CEA during follow-up. ISR management remains a challenge for clinicians. In this
observational retrospective analysis, we evaluated the operative management of ISR by standard CEAwith stent removal,
including midterm follow-up in 15 patients.
Methods: The present analysis included 15 patients from three Dutch vascular centers who underwent CEA for
symptomatic (n 10) or hemodynamically significant (>80%) asymptomatic ISR (n 5).Median time between CAS and
CEA was 18.3 months (range, 0-51 months).
Results: Standard CEA with stent removal was performed in all 15 patients. A Javid shunt was used in two procedures.
One patient sustained an intraoperative minor ischemic stroke, with complete recovery during the first postoperative
days. No neurologic complications occurred in the other 14 patients. Two patients required a reoperation to evacuate a
neck hematoma. There were no peripheral nerve complications. After a median follow-up of 21 months (range, 3-100
months), all 15 patients remained asymptomatic and without recurrent restenosis (>50%) on duplex ultrasound imaging.
Conclusion: CEA with stent explantation for ISR after CAS seems an effective and durable therapeutic option, albeit with
potential cerebral and bleeding complications, as in this study. The optimal treatment for carotid ISR, however, has yet
to be defined. (J Vasc Surg 2011;54:87-92.)
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fCarotid angioplasty and stenting (CAS) has emerged as
an alternative to carotid endarterectomy (CEA) for the
treatment of carotid obstructive disease in the prevention of
stroke. CAS, however, is hampered by a higher risk for
periprocedural adverse events compared with CEA.1More-
over, in the longer-term, the rate of in-stent restenosis
(ISR) after CAS is believed to be about three times higher
than after CEA, depending on the definition used and the
duration of follow-up.2,3
Although ISR after CAS is associated with recurrent
ipsilateral cerebrovascular symptoms, the risk of recurrent
ipsilateral stroke is low.4 Treatment options for ISR, such as
repeated angioplasty, CEA, and carotid bypass reconstruc-
tion, all carry a potential periprocedural risk of stroke. In
recent years, endovascular and open techniques have both
been reported with high success rates in treating ISR with
low complication rates. Reported series are small, however,
and the follow-up period is usually limited to several
months.5-9 Therefore, long-term outcome of ISR treat-
ment remains important.
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doi:10.1016/j.jvs.2010.11.118The present study reports 15 patients who developed
ymptomatic or hemodynamically significant asymptomatic
SR during follow-up and were treated by standard CEA
ith stent explantation. To our knowledge, this is the
argest series of patients in the current literature with sur-
ical management for ISR, including midterm follow-up.
ETHODS
Study design. Three high-volume tertiary vascular re-
erral centers in The Netherlands participated in this study:
niversity Medical Center Utrecht (UMCU), Erasmus
edical Center (EMC), and St Antonius Hospital (SAH).
ll patients treated by a surgical reintervention due to
ymptomatic or hemodynamically significant ISR after CAS
etween January 1996 and December 2009 were selected
rom our prospectively kept database and were analyzed
etrospectively.
Carotid stent protocol. Experienced interventional
pecialists in the three participating centers performed CAS
sing fixed fluoroscopic equipment. After local anesthesia,
ercutaneous access to the common femoral artery was
ained under ultrasound guidance. An introduction sheath
as placed, and a guiding catheter was positioned in the
ommon carotid artery. The use of an embolic protection
evice was at the discretion of the treating physician. Heart
ate and blood pressure monitoring were performed
hroughout the procedure and were combined with con-
inuous electrocardiography at UMCU and EMC.
Predilatation with an angioplasty balloon was per-
ormed when deemed necessary. Appropriately sized self-
xpandable or balloon-expandable stents were positioned.
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made the choice of stent type and placement. After stent
deployment, balloon angioplasty was executed at the point
of residual stenosis by using a percutaneous transluminal
angioplasty balloon. Angiographic success after CAS was
defined as 30% residual stenosis.
The duration of the procedure and the occurrence of
neurologic adverse events during the procedure were re-
corded. All patients were examined preoperatively and
postoperatively by an independent vascular neurologist. All
patients were taking aspirin (38-100 mg) at least since the
onset of symptoms or diagnosis of a significant stenosis of
the treated internal carotid artery. This use was continued
indefinitely. Clopidogrel was started 3 days before the
procedure (first dose, 300 mg; thereafter, 75 mg daily).
The clopidogrel was continued for up to 30 days in five
patients (EMC) and up to 90 days in 10 patients (SAH and
UMCU), this due to different CAS protocols in the sepa-
rate institutions. A heparin bolus (5000-10,000 IU) was
administered during the procedure.
Duplex ultrasound scanning. Duplex ultrasound
(DUS) scanning was performed by trained staff at the
vascular laboratory in each center. Peak systolic velocity
(PSV), end diastolic velocity (EDV), and the ratio between
PSV of the internal carotid artery and common carotid
artery (ICA/CCA) were measured. The DUS criteria for
grading ISR differed slightly between the three centers.
The criterion for ISR50% was a PSV of 175 to 299 cm/s
in all centers. The criteria for ISR 70% were a PSV of
300 cm/s (EMC, SAH) or 330 cm/s (UMCU) and
EDV 140 cm/s and a PSV ICA/CCA ratio  3.8.10
Follow-up and patient selection. Patients had a clin-
ical evaluation andDUS follow-up at 3 and 12months after
CAS and yearly thereafter. DUS imaging was performed
outside of regular follow-up in case of neurologic events
and followed by computed tomography angiography
(CTA) or digital subtraction angiography (DSA) when
deemed necessary. Patients with a symptomatic hemody-
namically significant ISR 70% were evaluated by a multi-
disciplinary cerebrovascular committee featuring vascular
surgeons, interventional radiologists, neurologists, and
clinical neurophysiologists discussing the need for reinter-
vention. In asymptomatic patients, significant ISR con-
tralateral occlusion of the ICA or severe four-vessel disease
with critical cerebral perfusion through the stented ICA
were indications for reintervention. Each center consecu-
tively treated patients once the indication for reintervention
was clear.
The rate of ISR 50% in the participating centers and
the alternative treatment options being offered for ISR will
only briefly be discussed because they do not fit the scope of
this report. Patient demographics, cardiovascular risk fac-
tors, previous neck surgery or radiotherapy, and procedural
details of CAS and surgical reintervention were recorded
for all included patients.
Carotid endarterectomy. Standard CEA with re-
moval of the stent was performed. The use of antiplatelet
medication was not stopped before surgery. A vascular beurologist was present during the operation. Patients
ere monitored by electroencephalography or transcranial
oppler (TCD), or both. If the electroencephalogram
EEG) showed asymmetry or TCD showed significant flow
eduction in themiddle cerebral artery after cross clamping,
Javid shunt (Bard Peripheral Vascular Inc, Tempe, Ariz)
as placed.
The carotid bifurcation was identified and mobilization
rom the CCA to the ICA at a level proximal to the stent
as performed in order to place clamps proximally and
istally. Before cross clamping, 5000 IU of heparin was
dministered. The hypoglossal nerve was identified and
pared in all cases. No division of digastric muscle or jaw
uxation was needed to get adequate exposure, including
ephalad control. An average 5 cm length arteriotomy was
erformed over the stent. The length of the arteriotomy
epended on the length of the implanted stent device (in
ur population average stent length was 40 mm). In some
ases, the arterial wall showed some edema at the site of the
mplanted stent. The stent was removed in toto in all cases,
ncluding intimal endarterectomy until proximal and distal
esection planes were free from atherosclerotic debris. The
ntimal hyperplasia and stent could be removed as one
omplex, without cutting across the stent. A proximal and
istal intimal flap was fixated when necessary. In all cases,
he operating team described intimal hyperplasia, no stent
nder expansion was reported. Standard eversion endarter-
ctomy of the external carotid artery (ECA) was performed
uring all procedures. The decision for venous or pros-
hetic patch was left at the surgeon’s discretion, not dic-
ated by prior neck surgery or irradiation. Apart from TCD
o monitor cerebral blood flow during CEA, no perioper-
tive flow assessment or completion imaging was per-
ormed.
ESULTS
Over 1700 CAS procedures were performed during the
tudy period in the three participating institutions. In this
ohort, about 20% of the patients developed ISR with a
iameter reduction of50% (during a mean follow-up of 2
ears). Of these 20%, a small percentage develop symptom-
tic ISR, which requires reintervention. Less than 3% of the
atients with ISR were treated by repeated percutaneous
ransluminal angioplasty.
In the study period, 15 patients (10 men) with signifi-
ant ISR were treated by surgical intervention. Of these, 10
atients had a symptomatic restenosis, comprising an isch-
mic stroke in five, repetitive transient ischemic attacks in
our, and amaurosis fugax in one; and five patients had
symptomatic hemodynamically significant restenosis with
n  1) or without (n  4) contralateral occlusion. Initial
ndications for CAS were previous neck surgery (one pa-
ient had an ipsilateral carotid-subclavian bypass and 1
atient was treated for esophageal carcinoma by transhiatal
sophagectomy with neck anastomosis), cervical radiation
herapy (n  2), or severe cardiopulmonary comorbidity
n  5). The other six patients were treated by CAS after
eing enrolled in international trials comparing CAS and
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trial).
Implanted stent types were Cristallo Ideale (n  2;
Invatec SPA, Roncadelle, Italy), Carotid Wall Stent (n 
10; Boston Scientific, Natick, Mass), Palmaz stents (n 1;
Cordis Corporation, Miami Lakes, Fla), Precise stents (n
1; Cordis Corporation), and Acculink (n  1; Abbott,
Abbott Park, Ill). Predominantly nontapered stents were
placed: diameter was 6 mm (n  12). In case of tapered
stents, diameters of 6 to 8 mm (n  1) or 6 to 9 mm (n 
2) were used. Postdilatation during the initial CAS proce-
dure was performed in 93% of the CAS procedures. On
preoperative imaging, the restenotic lesions in stented ca-
rotid arteries were distributed between stenosis in the mid-
to-distal ICA (n  4), midstent stenosis at the location of
the carotid bulb (n  9), and stenosis located at the CCA
(n  2). In none of the patients was a preoperative occlu-
sion of the ECA described on duplex or CTA imaging.
The average age at the time of the surgical procedure
was 64.5 years. Baseline characteristics and an outline of
cardiovascular risk factors of all patients are reported in the
Table.
The average interval between CAS and surgical inter-
vention was 18.3 months (range, 0-51 months). One pa-
tient was operated on the same day of his CAS procedure
because of lumen narrowing and observed protrusion of
plaque through the stent struts during CAS.
In all patients, a standard CEA was performed under
general anesthesia. No additional procedures (eg, jaw lux-
ation) were needed to get adequate exposure. In 14 of 15
patients, the stent was positioned both in the CCA and
ICA, covering the orifice of the external carotid artery. One
stent was placed selectively in the ICA. The median stent
length used was 40mm. TheCCAwas clamped proximal to
the stent (Fig 1). Obtaining cephalad control of the ICA
could, in our experience, be performed as in primary CEA
surgery. Because most of the stents were placed over the
carotid bifurcation, clamping the CCA and distal part of the
ICA was not hampered by the presence of a stent. How-
ever, theoretically, in case of selective ICA stenting, or with
the use of longer length stents, it might be more difficult to
obtain cephalad control. The average length of the arteri-
otomy was 5 cm; there was no need to cut across the stent.
Table. Baseline characteristics
Baseline characteristics n %
Included patients 15
Gender: male 10 67
Mean age in years (range) 64.5 (55-79)
Diabetes mellitus 3 20
Treated hypertension 13 87
Treated hypercholesterolemia 14 93
History of cardiac symptoms 7 47
History of smoking 13 87
Previous ipsilateral neck surgery 2 13
Previous ipsilateral neck radiation 2 13Kunlin stitches were used in order to prevent dissection of ahe arterial wall distal to the site of the stent. Standard
version endarterectomy of the ECAwas performed during
ll procedures.
The EEG was used in 12 of 15 procedures, and a Javid
hunt was used in two patients because of asymmetry on
EG after cross-clamping. There were no additional diffi-
ulties during the dissection phase; the stent and carotid
laque in all cases could be completely removed as one
ingle complex. Some edema of the arterial wall was seen at
he site of the stent, but this did not hamper performing the
ndarterectomy. There were no signs of manifest periarte-
ial inflammation at the carotid bifurcation. Primary closure
f the arteriotomy was performed in two patients, and 13
rteriotomies were closed with a venous or prosthetic patch
Fig 2). No additional reconstructions or bypasses were
eeded. The average operating time was 161 minutes
range, 90-260 min), which is comparable to the operating
ime in redo CEA procedures in the contributing hospitals.
One patient sustained an ischemic stroke directly after
he procedure. During the operation of this patient, no
ntraoperative hypotension or excessive blood loss was
een. There were fluctuations in the TCD signal but no
mboli were observed. The patient suffered from aphasia
nd symptoms of impaired strength in the left leg directly
ollowing the procedure. A control TCD was performed,
ut there were no anomalies seen in the blood flow in the
edial cerebral artery. The neurological symptoms recov-
red completely in 24 hours. A computed tomography scan
ostoperatively showed no new ischemic brain lesions. The
xact pathophysiology of this perioperative stroke remained
nclear.
Two patients had to be reoperated because of rebleed-
ng resulting in large postoperational neck hematoma.
hese two patients underwent CEA at 25 and 90 days after
AS. Both patients were on maximum dual antiplatelet
herapy, which was not stopped perioperatively.
During a mean follow-up of 21 months (range, 3-100
onths), no adverse neurologic events were reported, all
atients remained asymptomatic, and no reinterventions
ere required. During follow-up, none of the patients
eveloped recurrent restenosis of 50% on DUS imaging.
ISCUSSION
Hemodynamically significant ISR after CAS requiring
eintervention is infrequent but clinically challenging. In
ur series, the results of CEA with stent explantation are
ood, with a periprocedural complication rate that con-
orms to the literature. The two patients who required a
eoperation because of neck hematoma had surgical inter-
ention 90 days after CAS and used both aspirin and
lopidogrel at the time of CEA, which might explain the
ematoma. On midterm follow-up, no recurrent stenosis
r adverse neurologic events were observed after surgical
eintervention for ISR after CAS.
Ultrasound imaging is the most commonly used tech-
ique to monitor carotid artery stenosis after treatment.
owever, ultrasound velocity criteria for patients after CAS
re not well established. The enhanced stiffness of the
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pressure relation of the carotid artery closer to that ob-
served in a rigid tube.11 The energy normally applied to
dilate the artery might result in increased velocity. Other
studies have addressed this hypothesis.12-15 Higher grades
of carotid artery restenosis are estimated in a stented artery
when velocity criteria for native arteries are applied. Despite
being based on small patient series, several authors have
proposed revised velocity criteria for grading ISR.10,16
The criteria for grading ISR as proposed in recent literature
were followed in the vascular laboratories in the participat-
ing centers. When ultrasound imaging showed hemody-
namically significant ISR, CTA or DSA was performed to
re-evaluate the grade of stenosis and confirm stent position
Fig 1.
Fig 2. Closure of arteriotomy.to plan surgical reintervention. tThe long-term results of CAS, especially restenosis
evelopment and late stroke occurrence, have not been well
ocumented. In the Carotid and Vertebral Artery Translu-
inal Angioplasty Study, restenosis of 70% was more
ommon after endovascular treatment compared with the
urgical approach.4 An important consideration is that
ost of the patients in their trial had balloon angioplasty
lone, without stent placement. Comparison between bal-
oon angioplasty and CAS shows a lower restenosis rate in
atients treated with CAS. Amore recent trial showed a rate
f severe stenosis or occlusion of 11% after CAS and 5%
fter CEA after 2 years of follow-up.17 Also in our own
xperience, the rate of restenosis after CAS is considerably
igher when compared with restenosis after primary CEA,
nd this seems especially so in patients with CAS for reste-
osis after prior CEA.2,3
A number of risk factors contribute to the occurrence
f ISR, such as prior stroke, transient ischemic attack,
maurosis fugax, and especially prior neck cancer with neck
adiation.18 Other studies have suggested predictors of ISR
re advanced age, female gender, implantation of multiple
tents, prior revascularization therapy, residual stenosis,
levated post procedural serum levels of acute-phase reac-
ants, and the use of balloon-expandable stents.19-21 New
nd improved techniques in endovascular treatment as well
s evolution in stent designmight reduce neointimal hyper-
lasia and therefore the degree of ISR in the future.22
An asymptomatic single vessel carotid stenosis is gen-
rally not treated in The Netherlands, nor is an asymptom-
tic ISR following CAS for initial symptomatic carotid
rtery disease. The natural risk of becoming symptomatic of
uch an asymptomatic single lesion is considered very low,
nd thereby not having the patient exposed to the associ-
ted procedural risk of the intervention is preferred. In the
in situ.hree participating centers, considering the indications for
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Volume 54, Number 1 Reichmann et al 91reintervention in asymptomatic patients, the decision for
reintervention was based on a consensus within a multidis-
ciplinary cerebrovascular committee. In asymptomatic sig-
nificant stenosis of the ICA with contralateral occlusion of
the ICA, cerebral perfusion is mostly depended on the
stenotic ICA and partly on the vertebral arteries in case of
an uninterrupted Circle of Willis. Four-vessel disease refers
to atherosclerosis of both ICA and vertebral arteries. Pro-
gressive stenosis or occlusion of one of these vessels might
seriously further compromise cerebral blood flow, hence
the indication for revascularization of the ICA.
Treatment of ISR remains a challenge, and the optimal
treatment remains unclear. Several techniques have been
described. A total of 35 cases with any form of surgery for
ISR have been reported.9 King et al23 published a case
report and literature review and concluded that surgical
management of ISR is a safe option. The largest series
described is by Raithel et al,24 who performed a standard
CEA with patch plasty (n 6) or a polytetrafluoroethylene
interposition graft (n  2). No morbidity or mortality was
reported in their series.
One of the main challenges for the vascular surgeon is
dissecting in scarred tissue and identifying the right cleav-
age plane for performing the endarterectomy. King et al23
described that, in approximately 50% of the reported cases,
difficulties in the dissection occurred because of periarterial
inflammation at the carotid bifurcation. Balloon angio-
plasty and stent implantation apply a transient strain to the
vessel wall that activates smoothmuscle cells andmodulates
a proliferative and inflammatory phase of vessel repair.25-27
The inflammatory reaction within the stented artery might
cause the stent to become adherent to the arterial wall, thus
making stent removal difficult. This periarterial inflamma-
tion and adhesion of the stent to the arterial wall was the
reason that some surgeons chose to perform a transposition
of the internal to the external carotid artery or to do bypass
surgery instead of CEA to avoid a dissection in the inflamed
area.28,29 The interval between CAS and surgery might
influence the severity of this vessel wall inflammatory reac-
tion and therefore influence the choice of the type of
surgical revascularization. Another major surgical challenge
is to remove the distal part of the stent because this is
usually placed in a nondiseased part of the ICA, potentially
resulting in a locally very fragile arterial structure.
We did not encounter severe periarterial inflammation
limiting the surgical approach of the carotid bifurcation in
our series of 15 patients. This might be due to the mean
interval of 18.3 months between CAS and the surgical
intervention. Routine CEA could be performed without
the need for additional reconstructions. There was no
difficulty identifying the dissection plane, and all stents and
underlying atherosclerotic plaque could be completely re-
moved without severe problems.
Although we present the largest series of surgically
treated significant ISR, the number of patients remains low.
From our experience, however, patients with an indication
for treatment of ISR could be safely scheduled for a stan-
dardized CEA with stent removal.Our series also describes the longest follow-up duration
fter surgical ISR treatment. During a mean follow-up
eriod of 21 months, no adverse neurologic events were
eported and no recurrent restenosis of 50% was mea-
ured; however, we cannot report long-term results yet.
Other limitations of this study are that we did not
nalyze data of all CAS procedures performed between
996 and 2009 in detail and determine all ISR. For the
cope of this report, we decided to only describe surgically
reated ISR. Patients with ISR after CAS were treated in
hree different centers by different multidisciplinary teams;
herefore, results may not be fully comparable. However,
e believe that this study shows good results of common
ractice in treating ISR in large vascular centers.
Current consensus is that CEA remains the gold stan-
ard as the primary treatment in carotid occlusive disease.
AS could provide clinicians with an alternative in specific
roups of patients, especially patients with a high perioper-
tive risk. The observed higher incidence of recurrent re-
tenosis after CAS compared with CEA is one of the disad-
antages of this treatment, thereby possibly limiting the
ong-term benefit in stroke prevention. Although the num-
er of CAS procedures worldwide has declined since the
CSS and Carotid Revascularization Endarterectomy vs.
tent Trial (CREST) reports,1,30 clinicians will be con-
ronted with severe ISR needing revascularization in the
pcoming years. The optimal treatment strategy for ISR is
till not clear, but standardized CEA with stent removal
eems an acceptable alternative.
ONCLUSION
CEA seems a feasible option for treating ISR after CAS
nd provides a durable solution for recurrent cerebrovascu-
ar adverse events and recurrent restenosis. The choice of
reatment for ISR remains arbitrary, but surgeons may
onsider CEA as an acceptable and durable alternative to
ndovascular reintervention when revascularization is indi-
ated.
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